1. Home
  2. CLWT vs GOVX Comparison

CLWT vs GOVX Comparison

Compare CLWT & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLWT
  • GOVX
  • Stock Information
  • Founded
  • CLWT 1971
  • GOVX 2001
  • Country
  • CLWT Hong Kong
  • GOVX United States
  • Employees
  • CLWT N/A
  • GOVX N/A
  • Industry
  • CLWT Professional and commerical equipment
  • GOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLWT Consumer Discretionary
  • GOVX Health Care
  • Exchange
  • CLWT Nasdaq
  • GOVX Nasdaq
  • Market Cap
  • CLWT 8.9M
  • GOVX 7.6M
  • IPO Year
  • CLWT 1997
  • GOVX N/A
  • Fundamental
  • Price
  • CLWT $1.22
  • GOVX $0.75
  • Analyst Decision
  • CLWT
  • GOVX Strong Buy
  • Analyst Count
  • CLWT 0
  • GOVX 4
  • Target Price
  • CLWT N/A
  • GOVX $10.50
  • AVG Volume (30 Days)
  • CLWT 12.1K
  • GOVX 2.7M
  • Earning Date
  • CLWT 04-30-2025
  • GOVX 08-05-2025
  • Dividend Yield
  • CLWT N/A
  • GOVX N/A
  • EPS Growth
  • CLWT N/A
  • GOVX N/A
  • EPS
  • CLWT 0.10
  • GOVX N/A
  • Revenue
  • CLWT $15,383,000.00
  • GOVX $5,591,576.00
  • Revenue This Year
  • CLWT N/A
  • GOVX N/A
  • Revenue Next Year
  • CLWT N/A
  • GOVX N/A
  • P/E Ratio
  • CLWT $13.52
  • GOVX N/A
  • Revenue Growth
  • CLWT N/A
  • GOVX N/A
  • 52 Week Low
  • CLWT $1.01
  • GOVX $0.43
  • 52 Week High
  • CLWT $1.70
  • GOVX $11.18
  • Technical
  • Relative Strength Index (RSI)
  • CLWT 68.24
  • GOVX 47.67
  • Support Level
  • CLWT $1.12
  • GOVX $0.60
  • Resistance Level
  • CLWT $1.17
  • GOVX $0.76
  • Average True Range (ATR)
  • CLWT 0.03
  • GOVX 0.08
  • MACD
  • CLWT 0.01
  • GOVX 0.02
  • Stochastic Oscillator
  • CLWT 100.00
  • GOVX 59.45

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: